Follow
Ove Andersen
Ove Andersen
Amager Hvidovre Hospital
Verified email at regionh.dk
Title
Cited by
Cited by
Year
Risk of COVID-19 in health-care workers in Denmark: an observational cohort study
K Iversen, H Bundgaard, RB Hasselbalch, JH Kristensen, PB Nielsen, ...
The Lancet Infectious Diseases 20 (12), 1401-1408, 2020
4682020
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble …
K Kofoed, O Andersen, G Kronborg, M Tvede, J Petersen, J Eugen-Olsen, ...
Critical care 11, 1-10, 2007
4182007
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
J Eugen‐Olsen, O Andersen, A Linneberg, S Ladelund, TW Hansen, ...
Journal of internal medicine 268 (3), 296-308, 2010
4072010
Twenty-four-hour mobility during acute hospitalization in older medical patients
MM Pedersen, AC Bodilsen, J Petersen, N Beyer, O Andersen, ...
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2013
2612013
Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial
IC Helmark, UR Mikkelsen, J Børglum, A Rothe, MCH Petersen, ...
Arthritis research & therapy 12, 1-11, 2010
2582010
Increased expression of TNF-α, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels
AS Lihn, B Richelsen, SB Pedersen, SB Haugaard, GS Rathje, ...
American Journal of Physiology-Endocrinology and Metabolism 285 (5), E1072-E1080, 2003
2042003
Infections following epidural catheterization
HM Holt, SS Andersen, O Andersen, B Gahrn-Hansen, K Siboni
Journal of Hospital Infection 30 (4), 253-260, 1995
1711995
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
S Lyngbæk, JL Marott, T Sehestedt, TW Hansen, MH Olsen, O Andersen, ...
International journal of cardiology 167 (6), 2904-2911, 2013
1602013
Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology
K Kofoed, UV Schneider, T Scheel, O Andersen, J Eugen-Olsen
Clinical chemistry 52 (7), 1284-1293, 2006
1482006
Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV‐infected patients receiving highly active antiretroviral therapy
O Andersen, J Eugen‐Olsen, K Kofoed, J Iversen, SB Haugaard
Journal of medical virology 80 (2), 209-216, 2008
1462008
Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study
TH Haupt, J Petersen, G Ellekilde, HH Klausen, CW Thorball, ...
Critical care 16, 1-9, 2012
1382012
Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration …
K Kofoed, J Eugen-Olsen, J Petersen, K Larsen, O Andersen
European Journal of Clinical Microbiology & Infectious Diseases 27, 375-383, 2008
1352008
Soluble urokinase receptor (SuPAR) in COVID-19–related AKI
TU Azam, HR Shadid, P Blakely, P O’Hayer, H Berlin, M Pan, P Zhao, ...
Journal of the American Society of Nephrology 31 (11), 2725-2735, 2020
1322020
Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study
LJH Rasmussen, S Ladelund, TH Haupt, G Ellekilde, JH Poulsen, ...
Emergency Medicine Journal 33 (11), 769-775, 2016
1242016
CRP and suPAR are differently related to anthropometry and subclinical organ damage
S Lyngbæk, T Sehestedt, JL Marott, TW Hansen, MH Olsen, O Andersen, ...
International journal of cardiology 167 (3), 781-785, 2013
1142013
Cardiac and proinflammatory markers predict prognosis in cirrhosis
S Wiese, C Mortensen, JP Gøtze, E Christensen, O Andersen, F Bendtsen, ...
Liver International 34 (6), e19-e30, 2014
1032014
Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events
T Sehestedt, S Lyngbaek, J Eugen-Olsen, J Jeppesen, O Andersen, ...
Atherosclerosis 216 (1), 237-243, 2011
992011
Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population
TH Haupt, T Kallemose, S Ladelund, LJH Rasmussen, CW Thorball, ...
Biomarker insights 9, BMI. S19876, 2014
862014
In vivo and in vitro antibacterial activity of conglutinin, a mammalian plasma lectin
P Friis‐Christiansen, S Thiel, SE Svehag, R Dessau, P Svendsen, ...
Scandinavian Journal of Immunology 31 (4), 453-460, 1990
851990
Feasibility and inter-rater reliability of physical performance measures in acutely admitted older medical patients
AC Bodilsen, HG Juul-Larsen, J Petersen, N Beyer, O Andersen, ...
PloS one 10 (2), e0118248, 2015
842015
The system can't perform the operation now. Try again later.
Articles 1–20